Litcius/Paper detail

TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers

Nisha Nagarsheth, Scott M. Norberg, Andrew Sinkoe, Sabina Adhikary, Thomas J. Meyer, Justin Lack, Andrew Warner, Colleen Schweitzer, Stacey L. Doran, Soumya Korrapati, Sanja Stevanović, Cornelia L. Trimble, Jennifer A. Kanakry, Mohammadhadi Bagheri, Erin Ferraro, Stephanie H. Astrow, Adrian Bot, William C. Faquin, David F. Stroncek, Nikolaos Gkitsas, Steven L. Highfill, Christian S. Hinrichs

2021Nature Medicine324 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCancerImmunotherapyT cellImmune systemCancer researchChimeric antigen receptorT-cell receptorAntigenImmunologyOncologyInternal medicineCAR-T cell therapy researchVirus-based gene therapy researchImmunotherapy and Immune Responses
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers | Litcius